CD4+ T-cell counts and interleukin-8 and CCL-5 plasma concentrations discriminate disease severity in children with RSV infection

Pediatric Research

Volumn 73, Issue 2, 2013, Pages 187-193

  Brand, Hanne K ^a   Ferwerda, Gerben ^a   Preijers, Frank ^a   De Groot, Ronald ^a   Neeleman, Chris ^a   Staal, Frank J T ^b   Warris, Adilia ^a   Hermans, Peter W M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; OXYGEN; RANTES;

ARTICLE; ARTIFICIAL VENTILATION; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CHILD; CLINICAL FEATURE; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; HUMAN; INFANT; LEUKOCYTE; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NASOPHARYNX; NATURAL KILLER CELL; NEWBORN; NOSE FEEDING; OXYGEN BREATHING; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; VIRUS LOAD;

AGE FACTORS; BIOLOGICAL MARKERS; BRONCHIOLITIS, VIRAL; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINE CCL5; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFLAMMATION MEDIATORS; INTERLEUKIN-8; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; VIRAL LOAD;

EID: 84873607049     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2012.163     Document Type: Article

References (39)

1. Black CP. Systematic review of the biology and medical management of respiratory syncytial virus infection. Respir Care 2003;48:209-31; discussion 231-3.
2. Boyce TG, Mellen BG, Mitchel EF Jr, Wright PF, Griffin MR. Rates of hospitalization for respiratory syncytial virus infection among children in medicaid. J Pediatr 2000;137:865-70.
3. Berger TM, Aebi C, Duppenthaler A, Stocker M. Prospective populationbased study of RSV-related intermediate care and intensive care unit admissions in Switzerland over a 4-year period (2001-2005). Infection 2009;37:109-16.
4. Henderson J, Hilliard TN, Sherriff A, Stalker D, Al Shammari N, Thomas HM. Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: A longitudinal birth cohort study. Pediatr Allergy Immunol 2005;16:386-92.
5. Nicholson KG, McNally T, Silverman M, Simons P, Stockton JD, Zambon MC. Rates of hospitalisation for influenza, respiratory syncytial virus and human metapneumovirus among infants and young children. Vaccine 2006;24:102-8.
6. Purcell K, Fergie J. Driscoll Children's Hospital respiratory syncytial virus database: risk factors, treatment and hospital course in 3308 infants and young children, 1991 to 2002. Pediatr Infect Dis J 2004;23:418-23.
7. Prais D, Danino D, Schonfeld T, Amir J. Impact of palivizumab on admission to the ICU for respiratory syncytial virus bronchiolitis: A national survey. Chest 2005;128:2765-71.
8. Mansbach JM, Clark S, Christopher NC, et al. Prospective multicenter study of bronchiolitis: predicting safe discharges from the emergency department. Pediatrics 2008;121:680-8.
9. Roback MG, Baskin MN. Failure of oxygen saturation and clinical assessment to predict which patients with bronchiolitis discharged from the emergency department will return requiring admission. Pediatr Emerg Care 1997;13:9-11.
10. Norwood A, Mansbach JM, Clark S, Waseem M, Camargo CA Jr. Prospective multicenter study of bronchiolitis: predictors of an unscheduled visit after discharge from the emergency department. Acad Emerg Med 2010;17:376-82.
11. Parker MJ, Allen U, Stephens D, Lalani A, Schuh S. Predictors of major intervention in infants with bronchiolitis. Pediatr Pulmonol 2009;44:358-63.
12. Walsh P, Rothenberg SJ, O'Doherty S, Hoey H, Healy R. A validated clinical model to predict the need for admission and length of stay in children with acute bronchiolitis. Eur J Emerg Med 2004;11:265-72.
13. Larranaga CL, Ampuero SL, Luchsinger VF, et al. Impaired immune response in severe human lower tract respiratory infection by respiratory syncytial virus. Pediatr Infect Dis J 2009;28:867-73.
14. Brandenburg AH, Kleinjan A, van Het Land B, et al. Type 1-like immune response is found in children with respiratory syncytial virus infection regardless of clinical severity. J Med Virol 2000;62:267-77.
15. Bont L, Heijnen CJ, Kavelaars A, et al. Peripheral blood cytokine responses and disease severity in respiratory syncytial virus bronchiolitis. Eur Respir J 1999;14:144-9.
16. Hassan MA, Eldin AM, Ahmed MM. T - helper2 /T - helper1 imbalance in respiratory syncytial virus bronchiolitis in relation to disease severity and outcome. Egypt J Immunol 2008;15:153-60.
17. Marodi L. Neonatal innate immunity to infectious agents. Infect Immun 2006;74:1999-2006.
18. Pinto RA, Arredondo SM, Bono MR, Gaggero AA, Diaz PV. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol. Pediatrics 2006;117:e878-86.
19. O'Donnell DR, Carrington D. Peripheral blood lymphopenia and neutrophilia in children with severe respiratory syncytial virus disease. Pediatr Pulmonol 2002;34:128-30.
20. Roe MF, Bloxham DM, White DK, Ross-Russell RI, Tasker RT, O'Donnell DR. Lymphocyte apoptosis in acute respiratory syncytial virus bronchiolitis. Clin Exp Immunol 2004;137:139-45.
21. de Vries E, de Bruin-Versteeg S, Comans-Bitter WM, et al. Longitudinal survey of lymphocyte subpopulations in the first year of life. Pediatr Res 2000;47(4 Pt 1):528-37.
22. Comans-Bitter WM, de Groot R, van den Beemd R, et al. Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr 1997;130:388-93.
23. De Weerd W, Twilhaar WN, Kimpen JL. T cell subset analysis in peripheral blood of children with RSV bronchiolitis. Scand J Infect Dis 1998;30:77-80.
24. Sheeran P, Jafri H, Carubelli C, et al. Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. Pediatr Infect Dis J 1999;18:115-22.
25. Bonville CA, Rosenberg HF, Domachowske JB. Macrophage inflammatory protein-1alpha and RANTES are present in nasal secretions during ongoing upper respiratory tract infection. Pediatr Allergy Immunol 1999;10:39-44.
26. Tian M, Liu F, Wen GY, Shi SY, Chen RH, Zhao DY. Effect of variation in RANTES promoter on serum RANTES levels and risk of recurrent wheezing after RSV bronchiolitis in children from Han, Southern China. Eur J Pediatr 2009;168:963-7.
27. Huang JL, Huang J, Duan ZH, et al. Th2 predominance and CD8+ memory T cell depletion in patients with severe acute respiratory syndrome. Microbes Infect 2005;7:427-36.
28. Kawasaki Y, Hosoya M, Kanno H, Suzuki H. Serum regulated upon activation, normal T cell expressed and presumably secreted concentrations and eosinophils in respiratory syncytial virus infection. Pediatr Int 2006;48:257-60.
29. Culley FJ, Pennycook AM, Tregoning JS, et al. Role of CCL5 (RANTES) in viral lung disease. J Virol 2006;80:8151-7.
30. Hotchkiss RS, Opal S. Immunotherapy for sepsis-a new approach against an ancient foe. N Engl J Med 2010;363:87-9.
31. Said EA, Dupuy FP, Trautmann L, et al. Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection. Nat Med 2010;16:452-9.
32. Avota E, Gassert E, Schneider-Schaulies S. Measles virus-induced immunosuppression: from effectors to mechanisms. Med Microbiol Immunol 2010;199:227-37.
33. Malamitsi-Puchner A, Sarandakou A, Tziotis J, Economou E, Protonotariou E, Rigopoulou O. Chemokines Rantes and interleukin-8 in the perinatal period: changes in serum concentrations. Am J Perinatol 2004;21:235-40.
34. Sarafidis K, Diamanti E, Taparkou A, Tzimouli V, Drossou-Agakidou V, Kanakoudi-Tsakalidou F. Plasma RANTES increase during the first month of life independently of the feeding mode. Eur J Pediatr 2007;166:819-23.
35. Carroll KN, Wu P, Gebretsadik T, et al. The severity-dependent relationship of infant bronchiolitis on the risk and morbidity of early childhood asthma. J Allergy Clin Immunol 2009;123:1055-61, 1061.e1.
36. Smyth RL, Openshaw PJ. Bronchiolitis. Lancet 2006;368:312-22.
37. Hogatt J. Personalized medicine - trends in molecular diagnostics: exponential growth expected in the next ten years. Mol Diagn Ther 2011;15:53-5.
38. Quinn B. Payers and the assessment of clinical utility for companion diagnostics. Clin Pharmacol Ther 2010;88:751-4.
39. Templeton KE, Scheltinga SA, Beersma MF, Kroes AC, Claas EC. Rapid and sensitive method using multiplex real-time PCR for diagnosis of infections by influenza a and influenza B viruses, respiratory syncytial virus, and parainfluenza viruses 1, 2, 3, and 4. J Clin Microbiol 2004;42: 1564-9.